Maiken Keson-brookes - Net Worth and Insider Trading
Maiken Keson-brookes Net Worth
The estimated net worth of Maiken Keson-brookes is at least $165,485 dollars as of 2025-01-19. Maiken Keson-brookes is the See Remarks of Mural Oncology PLC and owns about 41,295 shares of Mural Oncology PLC (MURA) stock worth over $165,180. Maiken Keson-brookes is also the CLO & Corp. Secretary of Rubius Therapeutics Inc and owns about 5,343 shares of Rubius Therapeutics Inc (RUBY) stock worth over $305. Details can be seen in Maiken Keson-brookes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Maiken Keson-brookes has not made any transactions after 2024-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Maiken Keson-brookes
Maiken Keson-brookes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Maiken Keson-brookes owns 2 companies in total, including Rubius Therapeutics Inc (RUBY) , and uniQure NV (QURE) .
Click here to see the complete history of Maiken Keson-brookes’s form 4 insider trades.
Insider Ownership Summary of Maiken Keson-brookes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2022-02-01 | CLO & Corp. Secretary |
| QURE | uniQure NV | 2017-01-01 | General Counsel |
Maiken Keson-brookes Latest Holdings Summary
Maiken Keson-brookes currently owns a total of 2 stocks. Among these stocks, Maiken Keson-brookes owns 41,295 shares of Mural Oncology PLC (MURA) as of December 23, 2024, with a value of $165,180 and a weighting of 99.82%. Maiken Keson-brookes also owns 5,343 shares of Rubius Therapeutics Inc (RUBY) as of February 1, 2022, with a value of $305 and a weighting of 0.18%.
Latest Holdings of Maiken Keson-brookes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MURA | Mural Oncology PLC | 2024-12-23 | 41,295 | 4.00 | 165,180 |
| RUBY | Rubius Therapeutics Inc | 2022-02-01 | 5,343 | 0.06 | 305 |
Holding Weightings of Maiken Keson-brookes
Maiken Keson-brookes Form 4 Trading Tracker
According to the SEC Form 4 filings, Maiken Keson-brookes has made a total of 2 transactions in Mural Oncology PLC (MURA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Mural Oncology PLC is the sale of 2,555 shares on December 23, 2024, which brought Maiken Keson-brookes around $8,355.
According to the SEC Form 4 filings, Maiken Keson-brookes has made a total of 2 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Rubius Therapeutics Inc is the sale of 2,732 shares on February 1, 2022, which brought Maiken Keson-brookes around $17,949.
Insider Trading History of Maiken Keson-brookes
- 1
Maiken Keson-brookes Trading Performance
Maiken Keson-brookes Ownership Network
Ownership Network List of Maiken Keson-brookes
Ownership Network Relation of Maiken Keson-brookes
Maiken Keson-brookes Owned Company Details
What does Rubius Therapeutics Inc do?
Who are the key executives at Rubius Therapeutics Inc?
Maiken Keson-brookes is the CLO & Corp. Secretary of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .
Rubius Therapeutics Inc (RUBY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rubius Therapeutics Inc Insider Transactions
Maiken Keson-brookes Mailing Address
Above is the net worth, insider trading, and ownership report for Maiken Keson-brookes. You might contact Maiken Keson-brookes via mailing address: 35 Oak Hill Road, Fayville Ma 01745.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
